Ensign falls 1.5% as sector slips ahead of scheduled earnings call

What happened

Ensign (ENSG) fell 1.5% on October 23, 2026, as the healthcare sector median fell 1.2% and investors positioned ahead of the company’s third-quarter report and an October 28 earnings call. The stock opened 0.5% below the previous close and finished the session at $175.59, trading on volume that was 0.8 times its 20-day average. The S&P 500 fell 0.5% on the day.

How big was the move

The session’s move equalled 1.2 times a typical daily move for the stock and was 0.4 percentage points worse than the sector median. Over the last five sessions the stock fell 0.6% while the S&P 500 over five sessions fell 0.5%. With a beta of 0.12 the stock tends to move less than the market, suggesting this was largely a sector-driven shift rather than stock-specific news.

The technical picture

Technically, the stock sat 1.0% above its 20-day moving average and 0.3% above its 50-day moving average, but remained 3.3% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) was 52, in a neutral range, and the stock was 19.5% below its 52-week high. Over one month the stock rose 1.3%, over three months it fell 1.4%, and over one year it fell 5.0%, leaving it 18.8 percentage points behind the S&P 500.

Fundamentals and valuation

For the four quarters through June 30, 2026, the company reported revenue of $5.49 billion, up 18.9% from a year earlier, and diluted earnings per share of $6.38, up 15.8%. Gross margin narrowed to 14.1% from 15.9% a year earlier, while operating margin was 8.5% versus 8.6% a year earlier. Free-cash-flow margin stood at 7.6% and return on invested capital was 7.1%. The balance sheet showed net debt of 3.2 times EBITDA, and share count over one year increased by 1.5%.

On valuation, the stock traded at 27.5 times trailing earnings and 22.5 times expected earnings, with a free-cash-flow yield of 4.1%. Its price to trailing earnings was higher than 57% of its own readings over the past five years, with a five-year median of 25.0 times earnings. PromtFinance scores ranked the company strong on Value at 80, positive on Growth at 72, and exceptional on Stability at 93, reflecting solid company fundamentals despite the contraction in margins.

Earnings and analyst expectations

Ensign’s next report is scheduled for November 2, 2026. The company said it expects to release its third-quarter 2026 financial results and will hold an earnings call on Wednesday, October 28, 2026, according to GlobeNewsWire. In the last report, on July 27, 2026, the company posted earnings per share of $1.92 against $1.80 expected, 6.7% above estimates. The company has reported 14 consecutive quarters beating estimates, with an average surprise over the last four reports of 3.9% above estimates, and the typical two-day reaction after recent reports was the stock rose 0.8%.

Analysts had a consensus price target of $215.00, 22.4% above the closing price. Thirteen analysts had ratings on the stock, with 69% rating the stock Buy or Strong Buy and a consensus rating of Buy. With a market value of $10.23 billion, the gap between the current price and the consensus target highlights the market’s differing views on the outlook for margins and leverage.

What to watch

• October 28, 2026: Ensign will hold an earnings call announcing third-quarter 2026 results, as stated by GlobeNewsWire.
• November 2, 2026: The scheduled next report date for Ensign’s results.
• Recent margins: gross margin of 14.1% versus a year-earlier 15.9% and operating margin of 8.5% versus 8.6% a year earlier.
• Valuation: price to trailing earnings of 27.5 times and price to forward earnings of 22.5 times expected earnings.